Cancer Patients during COVID-19 Pandemic: A Mini-Review

Since its emergence, coronavirus disease 2019 (COVID-19) has affected the entire world and all commerce and industries, including healthcare systems. COVID-19 adversely affects cancer patients because they are immunocompromised. Increased COVID-19 infection and shortage of medical supplies, beds and...

Full description

Saved in:
Bibliographic Details
Published in:Healthcare (Basel) 2023-01, Vol.11 (2), p.248
Main Authors: Linjawi, Maryam, Shakoor, Hira, Hilary, Serene, Ali, Habiba I, Al-Dhaheri, Ayesha S, Ismail, Leila Cheikh, Apostolopoulos, Vasso, Stojanovska, Lily
Format: Article
Language:English
Subjects:
Biomarkers
Cancer therapies
Chemotherapy
COVID-19
Cytokines
Hypoxia
Infections
Intensive care
Lung cancer
Mortality
Pandemics
Patients
Proteins
Review
Severe acute respiratory syndrome coronavirus 2
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since its emergence, coronavirus disease 2019 (COVID-19) has affected the entire world and all commerce and industries, including healthcare systems. COVID-19 adversely affects cancer patients because they are immunocompromised. Increased COVID-19 infection and shortage of medical supplies, beds and healthcare workers in hospitals affect cancer care. This paper includes a description of the existing research that shows the impact of COVID-19 on the management of cancer patients. Aged people with various chronic conditions such as cancer and comorbidities face more challenges as they have a greater risk of disease severity. COVID-19 has affected care delivery, including patient management, and has been responsible for increased mortality among cancer patients. Cancer patients with severe symptoms require regular therapies and treatment; therefore, they have a higher risk of exposure. Due to the risk of transmission, various steps were taken to combat this disease; however, they have affected the existing operational efficiency. Herein, we present the changing priorities during COVID-19, which also affected cancer care, including delayed diagnosis, treatment, and surgeries.
ISSN:2227-9032
2227-9032
DOI:10.3390/healthcare11020248